The acronym may have a resemblance to a breakfast cereal.
But according to an investment note written by Goldman Sachs analyst Guillaume Jaisson, the 11 European stocks encapsulated by GRANOLAS - GSK, Roche, ASML, Nestle, Novartis, Novo Nordisk, L’Oreal, LVMH , AstraZeneca, SAP and Sanofi - could provide suitable diversification to portfolios dominated by the “Magnificent 7”* US technology stocks that have powered the S&P 500 index to record highs.
Although its co...
Start a free trial now for access to breaking news and cutting edge analysis of the wealth management industry.
You are currently not logged in,
login to view the full article
start by clicking this button.
Need a subscription,
fill out the form here or
contact subs@thewealthnet.com
PAM Insight is the world’s leading independent provider of essential specialist news, analysis and comparative data for the fast-evolving world of wealth management.
Read more about PAM
